Sadia Rahman
Stock Analyst at Wells Fargo
(2.66)
# 2,725
Out of 4,512 analysts
12
Total ratings
77.8%
Success rate
9.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sadia Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Rated: Buy | $550 | $476.31 | +15.47% | 1 | Jul 13, 2026 | |
| DNTH Dianthus Therapeutics | Rated: Buy | $135 | $101.28 | +33.29% | 5 | Jun 17, 2026 | |
| VOR Vor Biopharma | Reiterated: Buy | $30 | $18.50 | +62.16% | 3 | May 13, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $55 | $29.88 | +84.07% | 3 | May 13, 2026 |
Vertex Pharmaceuticals
Jul 13, 2026
Rated: Buy
Price Target: $550
Current: $476.31
Upside: +15.47%
Dianthus Therapeutics
Jun 17, 2026
Rated: Buy
Price Target: $135
Current: $101.28
Upside: +33.29%
Vor Biopharma
May 13, 2026
Reiterated: Buy
Price Target: $30
Current: $18.50
Upside: +62.16%
Maze Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $55
Current: $29.88
Upside: +84.07%